SCHEMBL12519534

SCHEMBL12519534

Nc1ccc(Oc2ccnc(C=O)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.47
▸ MAPT P10636 6/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ MITF O75030 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ GFER P55789 1/20 0.47
▸ NLRP1 Q9C000 1/20 0.47
▸ NOD2 Q9HC29 1/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ APAF1 O14727 1/20 0.44
▸ MAOA P21397 2/20 0.41
▸ TEAD4 Q15561 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ PARP10 Q53GL7 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24512696 0.83 ALDH1A1 (0.46) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL14050309 0.81 NR4A1 (0.38) ALDH1A1SMN1; SMN2POLBLMNAKDM4E
SCHEMBL1890586 0.77 NOS3 (0.57) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL29788816 0.77 NOS3 (0.57) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6385450 0.76 ALDH1A1 (0.43) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5745528 0.74 — —
SCHEMBL29953193 0.74 — —
SCHEMBL573928 0.74 MAOA (0.53) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL178024 0.74 ALDH1A1 (0.55) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1208300 0.73 CCR1 (0.55) ALDH1A1MAPTMAPK1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011090760-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-07-28 — — WO disclosed
WO-2009158571-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS AND USES THEREOF (US) 2009-12-30 — — WO disclosed
Send feedback